HMGN

Healthcare Biotechnology

Hemagen Diagnostics, Inc.

$0.00
-0.00 -0.00% today

Price History

Not enough data

Key Stats

Market Cap
3,100.056
Avg Volume
313
52W High
$0.13
52W Low
$0.00
Div. Yield
0.0%

Valuation

P/B Ratio
-0.00
P/S Ratio
0.00
EV/EBITDA
-18.14
EV/Revenue
1.23

Margins

Gross Margin 39.9%
Operating Margin (5.0%)
Net Margin (22.4%)
EBITDA Margin (6.8%)

Growth & Returns

Revenue Growth (YoY)
(23.6%)
Return on Assets
(10.3%)

Liquidity & Leverage

Current Ratio
1.07
Quick Ratio
0.34
Total Cash
66,287
Total Debt
5.03M

About

Hemagen Diagnostics, Inc. provides human and veterinary diagnostic services worldwide. The company develops, manufactures, and markets VIRGO, a human clinical diagnostic line of immunoassays for the diagnosis of autoimmune and infectious diseases, and acute phase proteins. Its proprietary test kits are used to aid in the diagnosis of certain autoimmune and infectious diseases. It also provides human diagnostics, such as universal IFA components; supplies, controls and calibrators, accessories, and H-rotors; reagents, electrodes, equipment; and specialty assays, including Chagas, acute phase proteins, and cytokines. In addition, the company offers veterinary diagnostic products, such as equipment, reagents, supplies, accessories, and electrodes in chemistry, hematology, and electrolyte areas. Its products are used in laboratories, hospitals and blood banks. Hemagen Diagnostics, Inc. was incorporated in 1985 and is based in Columbia, Maryland.

www.hemagen.com